EDOC:NSD-Global X Telemedicine & Digital Health ETF (USD)

ETF | Others |

Last Closing

USD 10.06

Change

-0.16 (-1.57)%

Market Cap

USD 0.04B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+1.81 (+3.30%)

USD 54.00B
QQQM Invesco NASDAQ 100 ETF

+4.71 (+2.26%)

USD 38.66B
JEPQ JPMorgan Nasdaq Equity Premium..

+1.09 (+1.95%)

USD 20.93B
ACWI iShares MSCI ACWI ETF

+1.90 (+1.63%)

USD 19.56B
CGABL The Carlyle Group Inc. 4.625% ..

+0.45 (+2.50%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+4.11 (+6.51%)

USD 5.86B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 4.78B
TSLL Direxion Shares ETF Trust - Di..

+4.12 (+15.79%)

USD 4.68B
ETHA iShares Ethereum Trust ETF

+1.63 (+6.67%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

+1.40 (+2.01%)

USD 2.29B

ETFs Containing EDOC

HDOC:CA 98.44 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.59% 34% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.59% 25% F 46% F
Trailing 12 Months  
Capital Gain -0.59% 34% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.59% 25% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -14.11% 11% F 17% F
Dividend Return -14.11% 10% F 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.44% 39% F 83% B
Risk Adjusted Return -91.39% 2% F 5% F
Market Capitalization 0.04B 52% F 26% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.